Zelgen's Series B Round

Zelgen raised a round of funding on January 16, 2018.

Zelgen (泽璟生物) is a biopharmaceutical firm engaged in the research, development, production, and sales of drugs for cell strain, protein, antibody, and peptide.…

Articles about Zelgen's Series B Round: